Popular Articles

generic levitra
Electric and hybrid cars dominate
The usually choc-a-bloc bus parking lot at Makuhari Messe was deserted. There were no car company hoardings on the way to the Tokyo Motor Show venue either. Inside, the show was restricted to just three halls. There were no go-go girls in skimpy costumes dancing to loud techno beats. Missing in action were Ferrari and Lamborghini. No Jaguar or Aston Martin, either. Not even Volkswagen. The space normally occupied by the American giants was filled in with paintings by children – on an automotive theme, mind you.

payday loans canada
Wockhardt gets award for patents
Drug maker Wockhardt today said it has been chosen as the pharmaceutical company for the maximum number of patent filings and grants from India.

News of the day

Range bound trading continues
Support at 5,150, resistance at 5,300.
Management

Aurobindo Phrama gets USFDA nod for veterinary drug

Drug maker Aurobindo Pharma today said its US-based joint venture firm has received approval from the drug regulator for its anti-bacterial veterinary medicine. - Daiichi full-year losses narrow down to $2.2 bn - Aurobindo expands pact with Pfizer - Aurobindo expands licensing pact with Pfizer, adds 60 drugs - Piramal Life starts trial of new diabetes drug - Dr Reddy"s to invest Rs 750 crore in two SEZs - Rising rupee could help Ranbaxy negate loss in Q2 Cephazone Pharma, a joint venture between the company and US-based Medphamex, has received approval for its original abbreviated new animal drug application (ANDA) from the US Food and Drug Administration for its veterinary drug, Aurobindo Pharma said in a filing to the Bombay Stock Exchange. The drug, ceftiofur sodium sterile powder, is the generic version of Pfizer"s Naxcel and is used in the treatment of various bacterial infections in animals including dogs, swine, horses and cattle, the Hyderabad-based pharma company said. Shares of Aurobindo Pharma surged over 4 per cent to trade at Rs 385.50 in the late afternoon trade on the BSE.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):